In rats with TNBS-induced colitis, supplementation with RJ also reduced CD3+, CD5+, CD8+, and CD45+ T cells, the production of pro-inflammatory cytokines IL-1β and TNF-α, and the levels of COX-2 and NF-κB. Here, PTPRC is linked to colitis.